Skip to content

Stromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy

Effect of Infiltrative Treatment of Stromal Vascular Fraction in Patellar Tendinopathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04753853
Enrollment
30
Registered
2021-02-15
Start date
2021-07-01
Completion date
2025-05-05
Last updated
2025-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellar Tendinitis, Patellar Tendinopathy, Tendinopathy

Keywords

stromal vascular fraction, patellar tendinopathy, injection

Brief summary

The aim of the study is the evaluation of clinical and radiological results after the treatment of patellar tendinopathy through the injection of autologous ultrasound-guided, intra- and peri-tendon stromal vascular fraction.

Detailed description

After being informed about the study and potential risks, all patients giving written informed consent will be treated according to the study protocol. Every patients will undergo to a single peri- and intra- tendon injection with Autologous Stromal Vascula Fraction (SVF). At baseline and at every follow-ups patients will be evaluated clinically and radiologically. In particular, clinical evaluation and questionnaires will be performed at baseline, 1, 3, 6, 12 and 24 months visits, Ultrasound will be performed at baseline, 6 and 12 months visits. MRI will be performed at baseline and 6 months visits.

Interventions

PROCEDUREStromal Vascular Fraction injection

intra- and peri-tendon ultrasound-guided injection of Stromal Vascular Fraction

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Interventional Pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Ultrasound or MRI signs of patellar tendon pathology

Exclusion criteria

* BMI \> 30 * Patients suffering from: rheumatic diseases, diabetes, infectious processes, epilepsy, severe osteoporosis * Patients undergoing intra-tendon infiltration of another substance within the previous 6 months; * Patients who had patellar tendon surgery within the previous 12 months; * Immunodepression * On going systemic inflammatory diseases (stabilized outcomes of such diseases are not considered absolute contraindications).

Design outcomes

Primary

MeasureTime frameDescription
Victorian Institute of Sport Assessment-Patella (VISA-P) questionnaire6 monthsVISA-P score is a questionnaire that assesses symptoms, simple tests of function, and the ability to play sports. It contains 8 questions about patellar tendinosis, max score for asymptomatic individual is 100; theoretical minimum is 0

Secondary

MeasureTime frameDescription
EuroQol Visual Analogue Scale (EQ-VAS)Baseline, 1, 3, 6, and 12 months (at 24 month the questionnaire will be performed by telephone)EQ-VAS, which asks patients to indicate their overall health on a vertical visual analogue scale, ranging from worst possible to best possible health.
EQ-5D(EuroQol)Baseline, 1, 3, 6, and 12 months (at 24 month the questionnaire will be performed by telephone)the EQ-5D profile, asks patients to classify their health based on self-assessed levels of problems (no, some, extreme) on five dimensions.
Visual Analog Scale - VASBaseline, 1, 3, 6, and 12 months (at 24 month the questionnaire will be performed by telephone)Analogue scale represented by a line of 10 cm length, ranging from absence of pain to the worst imaginable pain
Victorian Institute of Sport Assessment-Patella (VISA-P) questionnaireBaseline, 1, 3, 6, and 12 months (at 24 month the questionnaire will be performed by telephone)VISA-P score is a questionnaire that assesses symptoms, simple tests of function, and the ability to play sports. It contains 8 questions about patellar tendinosis, max score for asymptomatic individual is 100; theoretical minimum is 0
MRI evaluationbaseline and 6 monthMRI performing and evaluation
ultrasoundbaseline, 6 and 12 monthsultrasound performing and thickness evaluation of the tendon
Tegner scoreBaseline, 1, 3, 6, and 12 months (at 24 month the questionnaire will be performed by telephone)Tegner's activity scale classifies the activity according to work and sports activities on a scale from 0 to 10. Zero represents disability because of knee problems and 10 represents soccer a national or international level.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026